Misplaced Pages

Etiracetam: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 06:37, 26 August 2007 editMysid (talk | contribs)Extended confirmed users13,497 edits →svg← Previous edit Revision as of 06:30, 19 January 2008 edit undoSmackBot (talk | contribs)3,734,324 editsm Date/fix the maintenance tags or gen fixes using AWBNext edit →
Line 26: Line 26:
*] *]


{{Template:Racetams}} {{Racetams}}


{{pharma-stub}} {{pharma-stub}}

Revision as of 06:30, 19 January 2008

Pharmaceutical compound
Etiracetam
Clinical data
Routes of
administration		Oral
Legal status
Legal status
  • Unscheduled (US)
Identifiers
IUPAC name
  • 2-(2-oxopyrrolidin-1-yl)butanamide
PubChem CID
CompTox Dashboard (EPA)
ECHA InfoCard100.111.445 Edit this at Wikidata
Chemical and physical data
FormulaC8H14N2O2
Molar mass170.209 g/mol g·mol
3D model (JSmol)
SMILES
  • CCC(C(=O)N)N1CCCC1=O

Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active optical form is levetiracetam.

See also

Racetams
Racetams
Phenylpiracetams
Racetam-like


Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:
Etiracetam: Difference between revisions Add topic